Metraipolis › archive › dc_ef49db07f90b

Safety and early organ preservation outcomes after dose escalation with MR-guided radiotherapy for rectal cancer (preRADAR): A phase I trial — Europe PMC PMID:42290893

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42290893
DOI
10.1016/j.ctro.2026.101191
License (as archived)
solo-consultazione
Archived
2026-11-01T07:51:17.826Z
SHA-256 of the archived text
9fc1c1bf88dae06abb59c0bc1489684587c434dff88356ef0484868466b09358
Stable URL of this page
https://metraipolis.com/documento/dc_ef49db07f90b

How to cite

Safety and early organ preservation outcomes after dose escalation with MR-guided radiotherapy for rectal cancer (preRADAR): A phase I trial — Europe PMC PMID:42290893 — Europe PMC (en), https://europepmc.org/article/MED/42290893 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ef49db07f90b (Metraipolis archive dc_ef49db07f90b, sha256 9fc1c1bf88dae06abb59c0bc1489684587c434dff88356ef0484868466b09358)
BibTeX
@misc{dcef49db07f90b,
  title = {Safety and early organ preservation outcomes after dose escalation with MR-guided radiotherapy for rectal cancer (preRADAR): A phase I trial — Europe PMC PMID:42290893},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42290893},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ef49db07f90b; sha256 9fc1c1bf88dae06abb59c0bc1489684587c434dff88356ef0484868466b09358},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42290893. Agents can read the archived copy with the MCP tool read_document.